What Are the Differences Between Moderna and Pfizer-BioNTech COVID-19 Vaccines?

Moderna vs Pfizer
Here are the differences between the Moderna and Pfizer-BioNTech COVID-19 vaccines.

COVID-19 vaccines were developed within a very short span, and they were found to be effective in most of the vaccinated population. Various varieties of vaccines were developed by different nations after conducting extensive research on the SARS-CoV-2 virus.

The U.S. Food and Drug Administration (FDA) has approved three vaccines so far, and Moderna and Pfizer-BioNTech vaccines are among them.

  • Moderna and Pfizer vaccines were made using messenger RNA (mRNA).
  • After entering the body, the mRNA provokes your immune system.
  • As a response to these vaccines, your body produces an immune response against spike protein—a special protein present on the surface of the SARS-CoV-2 virus.

Although Moderna and Pfizer vaccines are made using the same technology and have near similar effects on the body, there are certain differences among them that have been highlighted in the following table.

Table. The differences between the Moderna and Pfizer COVID-19 vaccines Vaccine name Moderna COVID-19 Vaccine Pfizer-BioNTech COVID-19 Vaccine Technology

mRNA vaccine
mRNA vaccine

Mode of action

The vaccine provides a tiny piece of genetic code from the SARS-CoV-2 virus to host immune cells and provoke them to produce antibodies against spike protein
The vaccine provides a tiny piece of genetic code from the SARS-CoV-2 virus to host immune cells and provoke them to produce antibodies against spike protein

Status

FDA-approved
FDA-approved

Authorization date

December 18, 2020
December 11, 2020

Age

18 years and older
12 years and older

Eligibility, Emergency use authorization

18 years and older
5 years and older

Dosage

Two doses 28 days apart

Two doses 21 days apart:

  • Two 10 mcg doses for individuals who are 5 to 11 years
  • Two 30 mcg doses for individuals who are 12 years and older
Booster dose

A single dose is given after:

  • 28 days in immunocompromised people
  • Six months in people who are fully vaccinated with two doses

A single dose is given after:

  • 28 days in immunocompromised people
  • Six months in people who are fully vaccinated with two doses
Fully effective

14 days after the second dose
14 days after the second dose

Effectiveness

(may vary as clinic trials are going on)

  • 94 percent in age groups 18 years and older
  • 90 percent of people with comorbidities such as diabetes and obesity
  • 91 percent in age groups 16 years and older
  • 89 percent of people with comorbidities such as obesity and diabetes
  • 100 percent in age groups 12 to 15 years
  • 91 percent in age groups 2 to 11 years
Protection

Against severe COVID-19
Against severe COVID-19

Highly effective against which viral mutations
  • Alpha variant
  • Beta variant
  • Delta variant
  • Eta variant
  • Kappa variant
  • Alpha variant
  • Beta variant
Side effects
  • Pain in the site of injection
  • Headache
  • Fatigue
  • Chills
  • Fever
  • Joint pain
  • Nausea
  • Muscle pain
  • Feeling unwell
  • Swelling of the lymph nodes

Rare:

  • Heart issues
  • Breathlessness
  • Rapid heart rate
  • Anaphylaxis
  • Pain in the site of injection
  • Headache
  • Fatigue
  • Chills
  • Fever
  • Joint pain
  • Nausea
  • Muscle pain
  • Feeling unwell
  • Swelling of the lymph nodes

Rare:

  • Heart issues
  • Breathlessness
  • Rapid heart rate
  • Anaphylaxis
FDA warning

Possible inflammation of the heart such as

  • Myocarditis
  • Pericarditis

Possible inflammation of the heart such as 

  • Myocarditis
  • Pericarditis
Clinical trials

Under phase III clinical trials
Under phase III clinical trials

Distributed

Free of cost
Free of cost

Are COVID-19 vaccines safe?

The U.S. Food and Drug Administration has approved COVID-19 vaccines as safe for humans after conducting various clinical trials on animals and healthy humans.

Every day, hundreds of thousands of physicians, nurses, elders, and others are immunized to show that the vaccines are safe. To date, millions of citizens have been fully vaccinated across the country.

Booster doses that are given to fully vaccinated people make their immunity strong against the SARS-Cov-2 virus.

Check Also

What Is the Best Operation to Lose Weight?

Weight loss surgery options Weight loss surgery, also known as bariatric surgery, is one of the most effective tools for weight loss for people with a BMI above 40. The best operation to lose weight depends on a variety of factors but gastric bypass and gastric sleeve are two clear frontrunners. Weight loss surgery, also …

What Are the Differences Between Moderna and Pfizer-BioNTech COVID-19 Vaccines?

Moderna vs Pfizer
Here are the differences between the Moderna and Pfizer-BioNTech COVID-19 vaccines.

COVID-19 vaccines were developed within a very short span, and they were found to be effective in most of the vaccinated population. Various varieties of vaccines were developed by different nations after conducting extensive research on the SARS-CoV-2 virus.

The U.S. Food and Drug Administration (FDA) has approved three vaccines so far, and Moderna and Pfizer-BioNTech vaccines are among them.

  • Moderna and Pfizer vaccines were made using messenger RNA (mRNA).
  • After entering the body, the mRNA provokes your immune system.
  • As a response to these vaccines, your body produces an immune response against spike protein—a special protein present on the surface of the SARS-CoV-2 virus.

Although Moderna and Pfizer vaccines are made using the same technology and have near similar effects on the body, there are certain differences among them that have been highlighted in the following table.

Table. The differences between the Moderna and Pfizer COVID-19 vaccines Vaccine name Moderna COVID-19 Vaccine Pfizer-BioNTech COVID-19 Vaccine Technology

mRNA vaccine
mRNA vaccine

Mode of action

The vaccine provides a tiny piece of genetic code from the SARS-CoV-2 virus to host immune cells and provoke them to produce antibodies against spike protein
The vaccine provides a tiny piece of genetic code from the SARS-CoV-2 virus to host immune cells and provoke them to produce antibodies against spike protein

Status

FDA-approved
FDA-approved

Authorization date

December 18, 2020
December 11, 2020

Age

18 years and older
12 years and older

Eligibility, Emergency use authorization

18 years and older
5 years and older

Dosage

Two doses 28 days apart

Two doses 21 days apart:

  • Two 10 mcg doses for individuals who are 5 to 11 years
  • Two 30 mcg doses for individuals who are 12 years and older
Booster dose

A single dose is given after:

  • 28 days in immunocompromised people
  • Six months in people who are fully vaccinated with two doses

A single dose is given after:

  • 28 days in immunocompromised people
  • Six months in people who are fully vaccinated with two doses
Fully effective

14 days after the second dose
14 days after the second dose

Effectiveness

(may vary as clinic trials are going on)

  • 94 percent in age groups 18 years and older
  • 90 percent of people with comorbidities such as diabetes and obesity
  • 91 percent in age groups 16 years and older
  • 89 percent of people with comorbidities such as obesity and diabetes
  • 100 percent in age groups 12 to 15 years
  • 91 percent in age groups 2 to 11 years
Protection

Against severe COVID-19
Against severe COVID-19

Highly effective against which viral mutations
  • Alpha variant
  • Beta variant
  • Delta variant
  • Eta variant
  • Kappa variant
  • Alpha variant
  • Beta variant
Side effects
  • Pain in the site of injection
  • Headache
  • Fatigue
  • Chills
  • Fever
  • Joint pain
  • Nausea
  • Muscle pain
  • Feeling unwell
  • Swelling of the lymph nodes

Rare:

  • Heart issues
  • Breathlessness
  • Rapid heart rate
  • Anaphylaxis
  • Pain in the site of injection
  • Headache
  • Fatigue
  • Chills
  • Fever
  • Joint pain
  • Nausea
  • Muscle pain
  • Feeling unwell
  • Swelling of the lymph nodes

Rare:

  • Heart issues
  • Breathlessness
  • Rapid heart rate
  • Anaphylaxis
FDA warning

Possible inflammation of the heart such as

  • Myocarditis
  • Pericarditis

Possible inflammation of the heart such as 

  • Myocarditis
  • Pericarditis
Clinical trials

Under phase III clinical trials
Under phase III clinical trials

Distributed

Free of cost
Free of cost

Are COVID-19 vaccines safe?

The U.S. Food and Drug Administration has approved COVID-19 vaccines as safe for humans after conducting various clinical trials on animals and healthy humans.

Every day, hundreds of thousands of physicians, nurses, elders, and others are immunized to show that the vaccines are safe. To date, millions of citizens have been fully vaccinated across the country.

Booster doses that are given to fully vaccinated people make their immunity strong against the SARS-Cov-2 virus.

Check Also

What Is the Best Operation to Lose Weight?

Weight loss surgery options Weight loss surgery, also known as bariatric surgery, is one of …

Leave a Reply